期刊： CLINICAL THERAPEUTICS, 2021; 43 (2)
Purpose: Studies have shown an increased risk for mortality in patients with psoriasis. Furthermore, research has demonstrated an inverse relationship......
期刊： CLINICAL THERAPEUTICS, 2021; 43 (3)
Purpose: For the treatment of cerebral edema, the use of glycerol, an osmotic agent, as well as mannitol, is popular in Asia. However, the relative th......
期刊： CLINICAL THERAPEUTICS, 2021; 43 (3)
Purpose: The purpose of this study was to explore the efficacy, safety, and tolerability of a novel cyclosporine formulation for dry eye disease (DED)......
期刊： CLINICAL THERAPEUTICS, 2021; 43 (2)
Purpose: The aim of this study is to prospectively investigate the influence of ADRB and COMT gene polymorphisms on postoperative outcomes of patients......
期刊： CLINICAL THERAPEUTICS, 2021; 43 (3)
Purpose: Antihypertensive agents are frequently prescribed in kidney transplant recipients (KTRs). However, the frequency and patterns of prescribing ......
期刊： CLINICAL THERAPEUTICS, 2021; 43 (4)
Purpose: To evaluate the pharmacokinetics, pharmacodynamics, safety, and tolerability of single-and multiple-dose SPH3127 in healthy individuals. Meth......
期刊： CLINICAL THERAPEUTICS, 2021; 43 (2)
Background: Henagliflozin, a novel selective inhibitor of sodium-glucose cotransporter 2, is under development as a treatment for type 2 diabetes mell......
期刊： CLINICAL THERAPEUTICS, 2021; 43 (5)
Purpose: This study assessed the long-term (10-year) tolerability and efficacy of a low-dose corticosteroid combined with mycophenolate mofetil (CS + ......
期刊： CLINICAL THERAPEUTICS, 2021; 43 (5)
Purpose: Bivalirudin as a thrombin inhibitor is proven to have a low risk of bleeding during percutaneous coronary intervention (PCI). Some evidence i......
期刊： CLINICAL THERAPEUTICS, 2021; 43 (4)
Purpose: There is a need for efficient, convenient, and inexpensive methods to accurately diagnose the clinical stage of lung cancer and evaluate the ......
期刊： CLINICAL THERAPEUTICS, 2021; 43 (3)
Purpose: The present study was conducted to evaluate the efficacy and tolerability of using an immune checkpoint inhibitor (ICI; programmed cell death......
期刊： CLINICAL THERAPEUTICS, 2021; 43 (3)
Purpose: The present study compared the interindividual variability in the pharmacodynamic (PD) and pharmacokinetic (PK) properties of a short-acting ......
期刊： CLINICAL THERAPEUTICS, 2021; 43 (3)
Purpose: The loss of serum hepatitis B surface antigen (HBsAg) in patients with chronic hepatitis B (CHB) is considered an ideal clinical outcome but ......
